News China to begin first in-human CRISPR trial next month Phase 1 trial will investigate safety and tolerability in non-small cell lung cancer.
News Fulcrum Therapeutics promises new drugs for rare disorders Company launched following $55 million series A funding round.
News Agenovir secures funding for CRISPR antiviral therapies Antiviral therapy specialist Agenovir has secured $10.6 million in funding from a series A funding round.
News Caribou gains $30m funding for CRISPR-Cas platform Genetic engineering specialist Caribou Biosciences has secured $30 million in a series B funding round.
News We’re No.1 in CRISPR gene-editing race, says AstraZeneca The technology known as CRISPR/Cas9 has been described as the 'holy grail' of genetic engineering, and has become the hottest research area because of its potential to cure many diseases by
News Scribe Therapeutics joins the IPO queue Scribe Therapeutics has become the latest biotech to announce plans to list on the Nasdaq as it advances its spin on CRISPR-based therapeutics.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
